Markus Pfirrmann

9PUBLICATIONS
51CO-AUTHORS
Molecular targetsPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 18, 2026
Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study.

|Feb 19, 2026
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.

Michael Lauseker, Tomasz Sacha, Hana Klamova

|Apr 15, 2025
Prognostic scoring systems in chronic myeloid leukaemia.

Michael Lauseker, Verena S Hoffmann, Markus Pfirrmann

|Jul 10, 2024
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial.

Fabio Efficace, Francois-Xavier Mahon, Johan Richter

|Mar 12, 2024
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.

Francois-Xavier Mahon, Markus Pfirrmann, Stéphanie Dulucq

|Dec 21, 2023
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib.

Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova

Pageof 2

Frequent Collaborators

7 joint publications

Susanne Saussele

4 joint publications

Andreas Hochhaus

4 joint publications

Johan Richter

4 joint publications

Tim H Brümmendorf